![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Friday, April 04, 2008 3:49:54 PM
http://www.fda.gov/cdrh/ode/idepolcy.html
Lots of information here regarding the process. I took a good look at the area of 'Interactive IDE Review'. It appears to me that this process involves a continuous contact with the Office of Device Evaluation (ODE), "rather than only at the completion of the review, deficient information can be addressed within fewer review cycles."
If I'm reading this right, I think this stock is way under valued! This interactive process appears to be a big advantage to Dean & Company towards getting the Dominion to market, sooner rather than later... (jmo)
FEATURED Cannabix Technologies to Deliver Innovative Breath Logix Alcohol Screening Device to Texas, USA • Jul 29, 2024 9:07 AM
INDEXR AI Merges With Moon Equity Holdings Corp. (MONI), Creating a Leading-edge Technology Company • MONI • Jul 29, 2024 9:59 AM
BNCM AND DELEX UNVEIL POST-MERGER MANAGEMENT PLANS • BNCM • Jul 29, 2024 9:00 AM
Glidelogic Corp. Announces Revolutionary AI-Generated Content Copyright Protection Solution • GDLG • Jul 26, 2024 12:30 PM
Southern Silver Files NI43-101 Technical Report for its Updated Preliminary Economic Assessment for the Cerro Las Minitas Project • SSV • Jul 25, 2024 8:00 AM
Greenlite Ventures Completes Agreement with No Limit Technology • GRNL • Jul 19, 2024 10:00 AM